Deadline approaching: regeneron pharmaceuticals, inc. (regn) investors who lost money urged to contact law offices of howard g. smith

Bensalem, pa.--(business wire)--law offices of howard g. smith reminds investors of the upcoming march 10, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased regeneron pharmaceuticals, inc. (“regeneron” or the “company”) (nasdaq: regn) securities between november 2, 2023 and october 30, 2024, inclusive (the “class period”). if you are an investor who suffered a loss in regeneron pharmaceuticals, inc. (regn), contact the law offices of howard g.
REGN Ratings Summary
REGN Quant Ranking